JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tabuchi, N.
Right arrow Articles by Wildevuur, C. R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tabuchi, N.
Right arrow Articles by Wildevuur, C. R. H.

J Thorac Cardiovasc Surg 1995;110:813-0818
© 1995 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypassAltered shear-induced pathway

Noriyuki Tabuchi, MDa, Rolf C. G. Gallandat Huet, MD, PhDb, Augueste Sturk, PhDc, Leon Eijsman, MD, PhDd, Charles R. H. Wildevuur, MD, PhDa

Groningen, Leiden, and Amsterdam, The Netherlands

Financially supported by Bayer AG, Leverkusen, Germany.

Received for publication July 20, 1994. Accepted for publication Dec. 22, 1994. Address for reprints: C. R. H. Wildevuur, MD, Department of Cardiopulmonary Surgery, Research Division, University Hospital, Oostersingel 59, 9713 EZ Groningen, The Netherlands.

Abstract

The impaired hemostasis of aspirin-treated patients is an annoying problem during and after cardiopulmonary bypass. The hemostatic function of platelets comprises two mechanisms: the shear-induced and the cyclooxygenase pathways. Because the latter is inhibited in aspirin-treated patients, the hemostatic function depends mainly on the former pathway. To investigate the effect of cardiopulmonary bypass on the shear-induced pathway, a double-blind study of preoperative aspirin treatment (325 mg) and placebo was conducted in 40 patients undergoing coronary artery bypass grafting. Postoperative blood loss was higher in the aspirin-treated patients than in the placebo-treated patients (p < 0.05). The shear-induced hemostasis was monitored by the in vitro bleeding test (Thrombostat), which mimics bleeding through an injured arteriole. The shear-induced pathway of aspirin-treated platelets was not affected before cardiopulmonary bypass, but it was impaired more during the operation (p < 0.01) and remained worse afterward (p < 0.05), compared with that of placebo-treated platelets. The inhibitory effects of aspirin on thromboxane production and on collagen-induced platelet aggregation remained throughout the operation. In aspirin-treated platelets, the aggregation capacity induced by adenosine diphosphate was inhibited before the operation (p < 0.05) and showed substantial recovery during the operation (p < 0.05). These results suggest that the shear-induced pathway of aspirin-treated platelets is more vulnerable to cardiopulmonary bypass than the pathway in normal platelets and causes severe impairment of hemostasis afterward. (J THORACCARDIOVASCSURG1995;110: 813-8)




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. Morawski, M. Sanak, M. Cisowski, M. Szczeklik, W. Szczeklik, J. Dropinski, T. Waclawczyk, R. Ulczok, and A. Bochenek
Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 791 - 796.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Tanaka, K. Kawahito, H. Adachi, and T. Ino
Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method
J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 837 - 841.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Hongo, J. Ley, S. E. Dick, and R. R. Yee
The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting
J. Am. Coll. Cardiol., July 17, 2002; 40(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. A. Hennein
Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Kawahito, E. Kobayashi, H. Iwasa, Y. Misawa, and K. Fuse
Platelet aggregation during cardiopulmonary bypass evaluated by a laser light-scattering method
Ann. Thorac. Surg., January 1, 1999; 67(1): 79 - 84.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The American Association for Thoracic Surgery.